threat
grow
number
bacteria
resist
antibiot
reemerg
previous
deadli
infect
emerg
new
infect
urgent
need
novel
therapeut
agent
silver
nano
form
use
increasingli
antibacteri
agent
may
extend
antibacteri
applic
emerg
reemerg
multidrugresist
pathogen
main
caus
nosocomi
diseas
worldwid
present
studi
complet
bottom
method
prepar
green
nanosilv
use
explor
action
nanosilv
emerg
bacillu
megaterium
mtcc
reemerg
pseudomona
aeruginosa
mtcc
pathogen
bacteria
studi
includ
analysi
bacteri
membran
damag
scan
electron
microscop
sem
well
altern
zeta
potenti
intracellular
leakag
work
observ
genuin
bactericid
properti
nanosilv
compar
broad
spectrum
antibiot
emerg
reemerg
mode
expos
nanosilv
membran
becom
scatter
origin
order
arrang
base
sem
observ
moreov
result
also
suggest
altern
zeta
potenti
enhanc
membran
permeabl
beyond
critic
point
lead
cell
death
leakag
intracellular
constitu
confirm
ga
chromatographymass
spectrometri
gcm
conclus
combin
result
suggest
specif
dose
nanosilv
may
destroy
structur
bacteri
membran
depress
activ
caus
bacteria
die
eventu
antibiot
deserv
much
credit
dramat
increas
life
expect
around
world
centuri
famou
physician
expert
note
discoveri
penicillin
earli
show
cur
power
lone
provid
collect
talent
physician
new
york
time
unfortun
inevit
sometim
bacteria
develop
resist
exist
antibiot
make
infecti
diseas
difficult
treat
resist
profil
probabl
smoulder
issu
year
nowaday
almost
like
switch
got
trigger
infecti
diseas
expert
alarm
prospect
effect
antibiot
may
avail
control
reemerg
previous
deadli
infect
emerg
new
infect
caus
drugresist
bacteria
near
futur
recent
outbreak
pneumonia
pseudomona
aeruginosa
tuberculosi
mycobacterium
tuberculosi
exampl
reemerg
within
region
also
focus
region
nation
intern
attent
threat
develop
reemerg
infecti
diseas
particular
southeast
asia
epicentr
type
diseas
inde
tuberculosi
pneumonia
reemerg
drugresist
form
southeast
asia
also
hotspot
emerg
infecti
diseas
particular
zoonot
diseas
result
mani
factor
includ
popul
growth
mobil
environment
chang
sever
acut
respiratori
syndrom
sar
nipah
viru
recent
pandem
influenza
mani
exampl
emerg
infecti
diseas
southeast
asia
diseas
caus
global
societ
impact
relat
unexpect
ill
emerg
infecti
diseas
caus
bacteria
less
terribl
exampl
howev
nonetheless
may
take
signific
increas
morbid
well
cost
relat
prolong
treatment
recent
year
infect
caus
bacteria
man
probabl
emerg
china
brain
abscess
infect
bacillu
megaterium
best
knowledg
infect
caus
bacteria
rare
report
caus
import
clinic
diseas
known
new
infecti
diseas
emerg
tomorrow
popul
protect
stay
one
step
ahead
microb
search
new
antimicrobi
drug
moreov
research
also
discov
bacteri
speci
resist
differ
class
antibiot
includ
new
synthet
drug
even
though
bacteria
never
expos
antibiot
studi
support
hypothesi
antibiot
resist
genet
rich
natur
phenomenon
deepli
embed
bacteri
pangenom
bacteria
evolv
slow
stop
type
nonpathogen
bacteria
creat
health
problem
difficult
control
convent
antibiot
henc
need
new
antibiot
control
resist
bacteria
must
act
sever
cellular
molecular
level
mode
action
nanosilv
known
specif
singl
sight
influenc
bacteri
membran
permeabl
mani
metabol
pathway
time
present
studi
aim
understand
antibacteri
activ
act
mechan
nanosilv
mechan
inhibit
emerg
b
megaterium
mtcc
reemerg
p
aeruginosa
mtcc
altern
overal
surfac
charg
destroy
membran
structur
consequ
leakag
import
intracellular
constitu
amino
acid
fatti
acid
organ
acid
sugar
acid
studi
repres
potenti
templat
design
novel
antibacteri
agent
overcom
issu
emerg
reemerg
infecti
diseas
medicin
plant
tinospora
cordifolia
select
gir
forest
region
gujarat
india
basi
medicin
properti
silver
nitrat
ar
grade
procur
thermo
fisher
scientif
vadodara
india
two
bacteri
strain
one
gram
posit
bacillu
megaterium
mtcc
one
gram
neg
pseudomona
aeruginosa
mtcc
clinic
isol
obtain
microbi
type
cultur
collect
mtcc
institut
microbi
technolog
chandigarh
india
bacteri
strain
cultiv
nutrient
broth
medium
ph
himedia
vadodara
india
shake
rpm
bacteri
cell
suspens
dilut
steril
milliq
water
ph
obtain
final
concentr
cfu
ml
four
broad
spectrum
antibiot
name
amoxicillin
sun
pharmaceut
ankleshwar
india
chloramphenicol
alp
pharmaceut
uttarakhand
india
trimethoprimsulfamethoxazol
abbott
healthcar
mumbai
maharashtra
linezolid
glenmark
pharmaceut
ankleshwar
india
use
bactericid
assay
chemic
use
studi
analyt
grade
sigma
aldrich
ahmedabad
india
prepar
aqueou
extract
g
dri
stem
powder
boil
conic
flask
ml
deionis
water
min
magnet
stirrer
rpm
mixtur
filter
filter
paper
stem
extract
collect
store
use
synthesi
nanosilv
aqueou
solut
silver
nitrat
agno
prepar
stem
extract
cordifolia
ad
ratio
dark
condit
reduct
silver
nitrat
room
temperatur
bioreduct
silver
nitrat
confirm
uvvi
spectrophotometr
agil
technolog
cari
analysi
dynam
light
scatter
dl
techniqu
use
determin
size
potenti
stabil
nanosilv
suspens
use
nanotrac
wave
surfac
morpholog
nanosilv
along
element
analysi
determin
scan
electron
microscop
zeiss
coupl
energi
dispers
xray
analysi
edx
facil
appli
acceler
voltag
kv
compar
antibacteri
activ
nanosilv
broad
spectrum
antibiot
effect
access
emerg
pathogen
bacillu
megaterium
mtcc
reemerg
pathogen
pseudomona
aeruginosa
mtcc
use
agar
well
diffus
assay
method
drug
choic
test
strain
use
prove
uniqu
bactericid
action
nanosilv
compar
convent
broad
spectrum
antibiot
name
amoxicillin
inhibit
bacteri
cell
wall
synthesi
trimethoprimsulfamethoxazol
inhibit
synthesi
protein
nucleic
acid
chloramphenicol
inhibit
bacteri
protein
synthesi
prevent
elong
process
linezolid
inhibit
initi
process
bacteri
protein
synthesi
earlier
stage
concentr
nanosilv
antibiot
adjust
concentr
bacteri
cell
cfuml
incub
h
zone
inhibit
measur
assay
perform
three
replic
standard
deviat
replic
calcul
sampl
bacteri
cultur
bacillu
megaterium
mtcc
pseudomona
aeruginosa
mtcc
mix
nanosilv
collect
h
prefix
glutaraldehyd
min
wash
two
time
buffer
postfix
h
osmium
tetroxid
wash
buffer
dehydr
process
conduct
ethanol
prior
analysi
sem
zeiss
model
sampl
dri
subject
analysi
kv
acceler
voltag
control
experi
conduct
absenc
nanosilv
bacteri
surfac
characteris
surfac
electr
charg
allow
measur
zeta
potenti
nanotrac
wave
model
bacteri
cultur
harvest
centrifug
rpm
min
cell
pellet
wash
three
time
mm
potassium
phosphat
buffer
solut
ph
final
resuspend
buffer
final
concentr
cfuml
wash
bacteri
cell
suspens
incub
nanosilv
h
zeta
potenti
also
carri
normal
autoclav
psi
min
bacteri
cell
averag
bacteri
size
sampl
also
measur
nanotrac
wave
model
autoclav
nontreat
treat
bacteri
cell
ambient
temperatur
gcm
profil
carri
detect
leakag
intracellular
constitu
nontreat
nanosilv
treat
bacteri
cell
zeta
potenti
known
volum
bacteri
supernat
water
vv
dri
nitrogen
turbo
evapor
biotag
follow
derivat
mg
ml
methoxyamin
hydrochlorid
solut
ml
pyridin
min
shaker
subsequ
sampl
silyl
min
n
obi
trimethylsili
trifluoroacetamid
bstfa
shaker
derivat
bacteri
supernat
analyz
ga
chromatographmass
spectromet
plu
shimadzu
japan
coupl
shimadzu
se
mass
select
detector
aliquot
supernat
inject
ms
capillari
column
mm
id
film
thick
use
split
less
inject
min
helium
ga
use
carrier
ga
flow
rate
mlmin
leakag
intracellular
compound
identifi
mass
spectra
analysi
mz
rang
nation
institut
standard
technolog
nist
librari
gcm
solut
softwar
calcul
similar
index
match
consid
accept
mass
spectrum
identifi
intracellular
compound
treat
bacteria
compar
spectrum
nontreat
bacteria
control
identifi
leakag
constitu
due
nanosilv
treatment
bacteri
surfac
gcm
profil
aqueou
stem
extract
cordifolia
also
carri
common
compound
cordifolia
aqueou
extract
nanosilv
treatment
bacteri
cultur
well
bacteri
suspens
without
silver
nanosilv
treatment
identifi
subtract
identifi
uniqu
compound
linkag
releas
due
nanosilv
treatment
bacteri
surfac
nanosilv
success
synthes
aqueou
stem
extract
cordifolia
mix
mm
silver
nitrat
solut
addit
plant
extract
silver
nitrat
solut
result
gradual
chang
colour
silver
nitrat
solut
light
yellow
dark
brown
indic
format
nanosilv
fig
similar
colour
chang
report
previou
studi
henc
confirm
complet
reaction
silver
nitrat
stem
extract
synthesi
nanosilv
confirm
uvvi
spectrophotomet
strong
specif
peak
synthes
nanosilv
obtain
nm
fig
dynam
light
scatter
data
show
synthes
nanosilv
rang
nm
fig
well
agreement
sem
result
fig
surfac
zeta
potenti
valu
nanosilv
measur
slightli
posit
found
mv
data
shown
fig
posit
charg
nanosilv
prevent
aggreg
increas
stabil
well
help
enhanc
antibacteri
activ
interact
neg
charg
biomolecul
bacteri
membran
sem
imag
sampl
show
format
spheric
nanosilv
aggreg
form
averag
nm
size
confirm
silver
edx
analysi
fig
c
edx
analysi
show
strong
peak
kev
typic
absorpt
metal
nanocrystallit
silver
due
uniqu
surfac
plasmon
reson
spr
therebi
confirm
format
nanosilv
presenc
addit
peak
oxygen
indic
nanosilv
got
oxid
form
silver
oxid
compar
antibacteri
activ
nanosilv
broad
spectrum
antibiot
assess
emerg
b
megaterium
mtcc
reemerg
p
aeruginosa
mtcc
bacteria
direct
comparison
nanosilv
broad
spectrum
antibiot
dose
rang
cfuml
inoculum
show
test
microorgan
develop
resist
antibiot
belong
differ
class
fig
mean
three
replic
diamet
inhibit
zone
around
well
nanosilv
broad
spectrum
antibiot
repres
tabl
inhibit
zone
nanosilv
obtain
studi
indic
nanosilv
potenti
control
emerg
reemerg
multidrugresist
pathogen
compar
test
antibiot
find
agre
previou
result
research
proven
nanosilv
exert
result
multidrugresist
bacteria
find
show
b
megaterium
mtcc
develop
resist
test
antibiot
except
linezolid
fig
linezolid
new
class
antibiot
call
oxazolidinon
use
control
emerg
drug
resist
gramposit
organ
unfortun
b
megaterium
mtcc
develop
resist
trimethoprimsulfamethoxazol
valuabl
combinatori
therapi
treat
varieti
infect
emerg
resist
trimethoprimsulfamethoxazol
disturb
combin
two
broad
spectrum
antibiot
act
synergist
wide
varieti
urinari
respiratori
tract
infect
limit
data
avail
infect
caus
b
megaterium
previou
data
resist
antibiot
except
cloxacillin
streptomycin
thu
care
investig
requir
increas
bacteri
resist
among
gramposit
speci
concern
respons
nosocomi
infecti
diseas
hand
p
aeruginosa
mtcc
develop
resist
test
broad
spectrum
antibiot
fig
find
bactericid
activ
nanosilv
multidrugresist
p
aeruginosa
exactli
accord
find
shown
lara
et
al
recent
year
p
aeruginosa
bacteria
resist
differ
class
antibacteri
agent
one
fear
bacteria
caus
pneumonia
high
antibiot
prescrib
rate
one
lead
caus
develop
antibiot
resist
microb
case
reemerg
infecti
diseas
howev
speed
resist
develop
vari
depend
antibiot
microb
overal
find
suggest
signific
differ
bactericid
efficaci
nanosilv
antibiot
emerg
b
megaterium
mtcc
reemerg
p
aeruginosa
mtcc
demonstr
bactericid
mechan
nanosilv
affect
known
resist
mechan
differenti
strain
suscept
strain
data
present
studi
novel
nanosilv
exhibit
excel
bactericid
effect
toward
emerg
reemerg
bacteri
infect
regardless
drug
resist
mechan
observ
membran
deform
upon
nanosilv
treatment
scan
nanosilv
treat
nontreat
bacteri
cell
use
sem
imag
indic
clump
nanosilv
bacteri
membran
treat
cell
nontreat
cell
fig
upon
interact
nanosilv
surfac
potenti
bacteri
membran
neutral
result
increas
surfac
tension
h
treatment
interact
result
surfac
potenti
chang
lead
membran
depolar
point
clump
result
bacteri
membran
becom
scatter
origin
order
arrang
scatter
membran
contain
cell
longer
remain
intact
often
found
aggreg
fig
surfac
charg
neutral
bacteri
cell
membran
import
target
site
certain
membran
act
compound
particularli
antimicrobi
properti
act
bacteri
cell
surfac
accord
observ
nanosilv
produc
altern
zeta
potenti
gramneg
gramposit
bacteria
shown
fig
initi
interact
nanosilv
cell
surfac
b
megaterium
mtcc
p
aeruginosa
mtcc
cell
display
zeta
potenti
respect
howev
dead
autoclav
bacteri
cell
b
megaterium
mtcc
p
aeruginosa
mtcc
lower
zeta
potenti
mv
compar
normal
bacteri
cell
data
shown
fig
studi
found
zeta
potenti
valu
move
toward
neutral
treatment
nanosilv
calcul
zeta
potenti
valu
b
megaterium
mtcc
p
aeruginosa
mtcc
differ
time
interv
shown
fig
signific
differ
zeta
potenti
b
megaterium
mtcc
compar
p
aeruginosa
mtcc
normal
expos
nanosilv
autoclav
moreov
also
found
magnitud
decreas
neg
zeta
potenti
bacteri
cell
surfac
found
greater
b
megaterium
mtcc
altern
found
time
depend
studi
till
h
well
low
valu
zeta
potenti
indic
interact
cation
nanosilv
neg
surfac
potenti
bacteri
surfac
interestingli
chang
zeta
potenti
nanosilv
correl
increas
bacteri
membran
permeabl
evid
gcm
analysi
fig
supplementari
materi
present
find
conform
earlier
report
state
surfac
neutral
bacteri
membran
lead
increas
cell
permeabl
gcm
base
secretom
analysi
import
applic
discov
mode
action
nanosilv
help
unravel
effect
nanosilv
membran
permeabl
bacteria
studi
leakag
intracellular
constitu
bacteri
cell
identifi
mass
spectra
retent
time
indic
chromatogram
extra
cellular
compon
bacteri
cell
treatment
nanosilv
fig
supplementari
materi
case
treat
bacteri
cell
constitu
plant
extract
synthes
nanosilv
gener
total
constitu
present
extracellular
materi
treat
cell
nontreat
cell
well
plant
extract
detect
gcm
shown
tabl
increas
uniqu
intracellular
compon
treat
cell
observ
compar
plant
extract
nontreat
cell
common
uniqu
compound
identifi
bacillu
megaterium
mtcc
pseudomona
aeruginosa
mtcc
treatment
nanosilv
along
plant
extract
depict
fig
total
compound
identifi
common
bmt
pat
ple
follow
uniqu
compound
bmt
pat
moreov
compound
found
common
pat
ple
natur
compound
identifi
treatment
sugar
organ
acid
amino
acid
fatti
acid
show
signific
differ
nontreat
cell
plant
extract
tabl
supplementari
materi
may
indic
nanosilv
found
interact
bacteri
cell
surfac
result
membran
damag
nanosilv
consid
novel
antibacteri
agent
offer
sever
advantag
broad
spectrum
antibacteri
activ
lower
tendenc
induc
resist
present
studi
demonstr
interact
green
synthes
nanosilv
exert
slight
stress
bacteri
cell
membran
altern
zeta
potenti
strong
antibacteri
activ
nanosilv
possess
potenti
serv
platform
develop
nanosilv
novel
antibacteri
drug
overcom
problem
emerg
b
megaterium
mtcc
reemerg
p
aeruginosa
mtcc
antibacteri
efficaci
nanosilv
multidrugresist
indic
mode
action
nanosilv
mode
action
exert
antibiot
henc
threat
multidrugresist
strain
bacteria
nanosilv
could
good
altern
control
emerg
reemerg
infecti
diseas
author
declar
alon
respons
write
content
paper
author
report
conflict
interest
research
work
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
author
declar
conflict
interest
